Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2008

PHARMANIAGA BERHAD

Financial Year End

31/12/2008
Quarter2
Quarterly report for the financial period ended30/06/2008
The figureshave not been audited

Attachments

Pharmaniaga 2Q2008.pdf
298 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2008
30/06/2007
30/06/2008
30/06/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
353,465
300,231
663,115
556,466
2Profit/(loss) before tax
21,088
12,181
48,462
22,411
3Profit/(loss) for the period
13,457
7,217
32,439
13,710
4Profit/(loss) attributable to ordinary equity holders of the parent
13,107
6,640
31,652
12,709
5Basic earnings/(loss) per share (sen)
12.25
6.21
29.59
11.88
6Proposed/Declared dividend per share (sen)
18.00
15.00
18.00
15.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.3900
3.2700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 30 June 2008 (2007 : nil).

A final tax exempt dividend of 18.0% (2006 : 15.0%) on 106,963,188 (2006 : 106,963,188) ordinary shares of RM1.00 each in respect of the previous financial year amounting to RM19,253,374 (2006 : RM16,044,478) was approved by shareholders on 22 May 2008 and paid on 2 July 2008.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced14 Aug 2008  
CategoryFinancial Results
Reference NoPB-080813-32637